Visualitza VHIO - Articles científics per autor "Agarwal, Neeraj"
Ara mostrant els elements 1-3 d 3
-
A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer
Agarwal, Neeraj; Azad, Arun; Carles Galceran, Joan; Chowdhury, Simon; McGregor, Bradley; Merseburger, Axel (Future Medicine, 2022-03) -
Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
Gulley, James L.; Borre, Michael; Vogelzang, Nicholas J.; Ng, Siobhan; Agarwal, Neeraj; Parker, Chris C.; Carles Galceran, Joan (American Society of Clinical Oncology, 2019-05-01) -
Plain language summary of the design of the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prostate cancer
Agarwal, Neeraj; Azad, Arun; Shore, Neal; Carles Galceran, Joan; Fay, Andre P; Dunshee, Curtis (Future Science Group, 2022-09)